aluates Reports

$ 0.0

Automative

Global Cell Therapy and Tissue Engineering Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-14M14263

Global Cell Therapy and Tissue Engineering Market Research Report 2023

BUY CHAPTERS

Global Cell Therapy and Tissue Engineering Market Insights, Forecast to 2030

Code: QYRE-Auto-14M14263

Report

December 2024

Pages:127

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Betalin Therapeutics

BioCardia

BioReliance Corporation

Biosolution Co.

Brainstorm Cell Therapeutics Inc.

MaxCyte

MediGene AG

MediPost Co Ltd

Mesoblast Limited

Miromatrix Medical, Inc.

Molmed

Mustang Bio, Inc

NantKwest Inc

Neuralstem Inc

NexImmune, Inc.

Nohla Therapeutics Inc

Rubius Therapeutics, Inc.

Sangamo Therapeutics, Inc.

Voyager Therapeutics Inc

Waisman Biomanufacturing

WindMIL Therapeutics, Inc.

Wuxi App Tec, Inc.

ReNeuron Group Plc

Richter-Helm BioLogics GmbH & Co. KG

RoosterBio, Inc

RoslinCT

Cell Therapy and Tissue Engineering Market

Market Analysis and Insights: Global Cell Therapy and Tissue Engineering Market

The global Cell Therapy and Tissue Engineering market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules. Cell therapy, genetically modified cell therapy, gene therapy and tissue engineering are the four pillars of Regenerative Medicine (RM). These therapies have the potential to beneficially alter the quality of life and improve the health of patients with cell defects, genetic diseases, neurodegenerative diseases, tissue malignancies and other medical conditions.

Report Covers:

This report presents an overview of global market for Cell Therapy and Tissue Engineering market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Cell Therapy and Tissue Engineering, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cell Therapy and Tissue Engineering, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell Therapy and Tissue Engineering revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cell Therapy and Tissue Engineering market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cell Therapy and Tissue Engineering revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Cell Therapy and Tissue Engineering Market Report

Report Metric	Details
Report Name	Cell Therapy and Tissue Engineering Market
Segment by Type	Cell Therapy Tissue Engineering
Segment by Application	Cell Defects Genetic Diseases Neurodegenerative Diseases Tissue Malignancies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Betalin Therapeutics, BioCardia, Inc, BioReliance Corporation, Biosolution Co., Brainstorm Cell Therapeutics, Inc, MaxCyte, Inc, Medigene AG, MEDIPOST CO., Mesoblast Limited, Miromatrix Medical, Inc., MolMed S.p.A, Mustang Bio, Inc, NantKwest, Inc., Neuralstem, Inc, NexImmune, Inc., Nohla Therapeutics, Inc, ReNeuron Group plc, Richter-Helm BioLogics GmbH & Co. KG, RoosterBio, Inc, RoslinCT, Rubius Therapeutics, Inc., Sangamo Therapeutics, Inc, Voyager Therapeutics, Inc, Waisman Biomanufacturing, WindMIL Therapeutics, Inc., Wuxi App Tec, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cell Therapy and Tissue Engineering in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Therapy and Tissue Engineering companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Therapy and Tissue Engineering revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Cell Therapy and Tissue Engineering Market report?

Ans: The main players in the Cell Therapy and Tissue Engineering Market are Betalin Therapeutics, BioCardia, Inc, BioReliance Corporation, Biosolution Co., Brainstorm Cell Therapeutics, Inc, MaxCyte, Inc, Medigene AG, MEDIPOST CO., Mesoblast Limited, Miromatrix Medical, Inc., MolMed S.p.A, Mustang Bio, Inc, NantKwest, Inc., Neuralstem, Inc, NexImmune, Inc., Nohla Therapeutics, Inc, ReNeuron Group plc, Richter-Helm BioLogics GmbH & Co. KG, RoosterBio, Inc, RoslinCT, Rubius Therapeutics, Inc., Sangamo Therapeutics, Inc, Voyager Therapeutics, Inc, Waisman Biomanufacturing, WindMIL Therapeutics, Inc., Wuxi App Tec, Inc.

What are the Application segmentation covered in the Cell Therapy and Tissue Engineering Market report?

Ans: The Applications covered in the Cell Therapy and Tissue Engineering Market report are Cell Defects, Genetic Diseases, Neurodegenerative Diseases, Tissue Malignancies, Others

What are the Type segmentation covered in the Cell Therapy and Tissue Engineering Market report?

Ans: The Types covered in the Cell Therapy and Tissue Engineering Market report are Cell Therapy, Tissue Engineering

Recommended Reports

Cell Therapy Markets

Tissue Engineering

Stem Cell Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Cell Therapy

1.2.3 Tissue Engineering

1.3 Market by Application

1.3.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Cell Defects

1.3.3 Genetic Diseases

1.3.4 Neurodegenerative Diseases

1.3.5 Tissue Malignancies

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cell Therapy and Tissue Engineering Market Perspective (2019-2030)

2.2 Global Cell Therapy and Tissue Engineering Growth Trends by Region

2.2.1 Cell Therapy and Tissue Engineering Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cell Therapy and Tissue Engineering Historic Market Size by Region (2019-2024)

2.2.3 Cell Therapy and Tissue Engineering Forecasted Market Size by Region (2025-2030)

2.3 Cell Therapy and Tissue Engineering Market Dynamics

2.3.1 Cell Therapy and Tissue Engineering Industry Trends

2.3.2 Cell Therapy and Tissue Engineering Market Drivers

2.3.3 Cell Therapy and Tissue Engineering Market Challenges

2.3.4 Cell Therapy and Tissue Engineering Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Cell Therapy and Tissue Engineering by Players

3.1.1 Global Cell Therapy and Tissue Engineering Revenue by Players (2019-2024)

3.1.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by Players (2019-2024)

3.2 Global Cell Therapy and Tissue Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Cell Therapy and Tissue Engineering, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Cell Therapy and Tissue Engineering Market Concentration Ratio

3.4.1 Global Cell Therapy and Tissue Engineering Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy and Tissue Engineering Revenue in 2023

3.5 Global Key Players of Cell Therapy and Tissue Engineering Head office and Area Served

3.6 Global Key Players of Cell Therapy and Tissue Engineering, Product and Application

3.7 Global Key Players of Cell Therapy and Tissue Engineering, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cell Therapy and Tissue Engineering Breakdown Data by Type

4.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Type (2019-2024)

4.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2025-2030)

5 Cell Therapy and Tissue Engineering Breakdown Data by Application

5.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Application (2019-2024)

5.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cell Therapy and Tissue Engineering Market Size (2019-2030)

6.2 North America Cell Therapy and Tissue Engineering Market Size by Type

6.2.1 North America Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)

6.2.2 North America Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)

6.2.3 North America Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)

6.3 North America Cell Therapy and Tissue Engineering Market Size by Application

6.3.1 North America Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)

6.3.2 North America Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)

6.3.3 North America Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)

6.4 North America Cell Therapy and Tissue Engineering Market Size by Country

6.4.1 North America Cell Therapy and Tissue Engineering Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Cell Therapy and Tissue Engineering Market Size by Country (2019-2024)

6.4.3 North America Cell Therapy and Tissue Engineering Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Cell Therapy and Tissue Engineering Market Size (2019-2030)

7.2 Europe Cell Therapy and Tissue Engineering Market Size by Type

7.2.1 Europe Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)

7.2.2 Europe Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)

7.2.3 Europe Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)

7.3 Europe Cell Therapy and Tissue Engineering Market Size by Application

7.3.1 Europe Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)

7.3.2 Europe Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)

7.3.3 Europe Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)

7.4 Europe Cell Therapy and Tissue Engineering Market Size by Country

7.4.1 Europe Cell Therapy and Tissue Engineering Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Cell Therapy and Tissue Engineering Market Size by Country (2019-2024)

7.4.3 Europe Cell Therapy and Tissue Engineering Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Cell Therapy and Tissue Engineering Market Size (2019-2030)

8.2 China Cell Therapy and Tissue Engineering Market Size by Type

8.2.1 China Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)

8.2.2 China Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)

8.2.3 China Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)

8.3 China Cell Therapy and Tissue Engineering Market Size by Application

8.3.1 China Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)

8.3.2 China Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)

8.3.3 China Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Cell Therapy and Tissue Engineering Market Size (2019-2030)

9.2 Asia Cell Therapy and Tissue Engineering Market Size by Type

9.2.1 Asia Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)

9.2.2 Asia Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)

9.2.3 Asia Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)

9.3 Asia Cell Therapy and Tissue Engineering Market Size by Application

9.3.1 Asia Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)

9.3.2 Asia Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)

9.3.3 Asia Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)

9.4 Asia Cell Therapy and Tissue Engineering Market Size by Region

9.4.1 Asia Cell Therapy and Tissue Engineering Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Cell Therapy and Tissue Engineering Market Size by Region (2019-2024)

9.4.3 Asia Cell Therapy and Tissue Engineering Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type

10.2.1 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application

10.3.1 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country

10.4.1 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Betalin Therapeutics

11.1.1 Betalin Therapeutics Company Details

11.1.2 Betalin Therapeutics Business Overview

11.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Introduction

11.1.4 Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.1.5 Betalin Therapeutics Recent Developments

11.2 BioCardia, Inc

11.2.1 BioCardia, Inc Company Details

11.2.2 BioCardia, Inc Business Overview

11.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Introduction

11.2.4 BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.2.5 BioCardia, Inc Recent Developments

11.3 BioReliance Corporation

11.3.1 BioReliance Corporation Company Details

11.3.2 BioReliance Corporation Business Overview

11.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Introduction

11.3.4 BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.3.5 BioReliance Corporation Recent Developments

11.4 Biosolution Co.

11.4.1 Biosolution Co. Company Details

11.4.2 Biosolution Co. Business Overview

11.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Introduction

11.4.4 Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.4.5 Biosolution Co. Recent Developments

11.5 Brainstorm Cell Therapeutics, Inc

11.5.1 Brainstorm Cell Therapeutics, Inc Company Details

11.5.2 Brainstorm Cell Therapeutics, Inc Business Overview

11.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction

11.5.4 Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.5.5 Brainstorm Cell Therapeutics, Inc Recent Developments

11.6 MaxCyte, Inc

11.6.1 MaxCyte, Inc Company Details

11.6.2 MaxCyte, Inc Business Overview

11.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Introduction

11.6.4 MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.6.5 MaxCyte, Inc Recent Developments

11.7 Medigene AG

11.7.1 Medigene AG Company Details

11.7.2 Medigene AG Business Overview

11.7.3 Medigene AG Cell Therapy and Tissue Engineering Introduction

11.7.4 Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.7.5 Medigene AG Recent Developments

11.8 MEDIPOST CO.

11.8.1 MEDIPOST CO. Company Details

11.8.2 MEDIPOST CO. Business Overview

11.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Introduction

11.8.4 MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.8.5 MEDIPOST CO. Recent Developments

11.9 Mesoblast Limited

11.9.1 Mesoblast Limited Company Details

11.9.2 Mesoblast Limited Business Overview

11.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Introduction

11.9.4 Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.9.5 Mesoblast Limited Recent Developments

11.10 Miromatrix Medical, Inc.

11.10.1 Miromatrix Medical, Inc. Company Details

11.10.2 Miromatrix Medical, Inc. Business Overview

11.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Introduction

11.10.4 Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.10.5 Miromatrix Medical, Inc. Recent Developments

11.11 MolMed S.p.A

11.11.1 MolMed S.p.A Company Details

11.11.2 MolMed S.p.A Business Overview

11.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Introduction

11.11.4 MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.11.5 MolMed S.p.A Recent Developments

11.12 Mustang Bio, Inc

11.12.1 Mustang Bio, Inc Company Details

11.12.2 Mustang Bio, Inc Business Overview

11.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Introduction

11.12.4 Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.12.5 Mustang Bio, Inc Recent Developments

11.13 NantKwest, Inc.

11.13.1 NantKwest, Inc. Company Details

11.13.2 NantKwest, Inc. Business Overview

11.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Introduction

11.13.4 NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.13.5 NantKwest, Inc. Recent Developments

11.14 Neuralstem, Inc

11.14.1 Neuralstem, Inc Company Details

11.14.2 Neuralstem, Inc Business Overview

11.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Introduction

11.14.4 Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.14.5 Neuralstem, Inc Recent Developments

11.15 NexImmune, Inc.

11.15.1 NexImmune, Inc. Company Details

11.15.2 NexImmune, Inc. Business Overview

11.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Introduction

11.15.4 NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.15.5 NexImmune, Inc. Recent Developments

11.16 Nohla Therapeutics, Inc

11.16.1 Nohla Therapeutics, Inc Company Details

11.16.2 Nohla Therapeutics, Inc Business Overview

11.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction

11.16.4 Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.16.5 Nohla Therapeutics, Inc Recent Developments

11.17 ReNeuron Group plc

11.17.1 ReNeuron Group plc Company Details

11.17.2 ReNeuron Group plc Business Overview

11.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction

11.17.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.17.5 ReNeuron Group plc Recent Developments

11.18 Richter-Helm BioLogics GmbH & Co. KG

11.18.1 Richter-Helm BioLogics GmbH & Co. KG Company Details

11.18.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview

11.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction

11.18.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.18.5 Richter-Helm BioLogics GmbH & Co. KG Recent Developments

11.19 RoosterBio, Inc

11.19.1 RoosterBio, Inc Company Details

11.19.2 RoosterBio, Inc Business Overview

11.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction

11.19.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.19.5 RoosterBio, Inc Recent Developments

11.20 RoslinCT

11.20.1 RoslinCT Company Details

11.20.2 RoslinCT Business Overview

11.20.3 RoslinCT Cell Therapy and Tissue Engineering Introduction

11.20.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.20.5 RoslinCT Recent Developments

11.21 Rubius Therapeutics, Inc.

11.21.1 Rubius Therapeutics, Inc. Company Details

11.21.2 Rubius Therapeutics, Inc. Business Overview

11.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction

11.21.4 Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.21.5 Rubius Therapeutics, Inc. Recent Developments

11.22 Sangamo Therapeutics, Inc

11.22.1 Sangamo Therapeutics, Inc Company Details

11.22.2 Sangamo Therapeutics, Inc Business Overview

11.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction

11.22.4 Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.22.5 Sangamo Therapeutics, Inc Recent Developments

11.23 Voyager Therapeutics, Inc

11.23.1 Voyager Therapeutics, Inc Company Details

11.23.2 Voyager Therapeutics, Inc Business Overview

11.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction

11.23.4 Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.23.5 Voyager Therapeutics, Inc Recent Developments

11.24 Waisman Biomanufacturing

11.24.1 Waisman Biomanufacturing Company Details

11.24.2 Waisman Biomanufacturing Business Overview

11.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Introduction

11.24.4 Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.24.5 Waisman Biomanufacturing Recent Developments

11.25 WindMIL Therapeutics, Inc.

11.25.1 WindMIL Therapeutics, Inc. Company Details

11.25.2 WindMIL Therapeutics, Inc. Business Overview

11.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction

11.25.4 WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.25.5 WindMIL Therapeutics, Inc. Recent Developments

11.26 Wuxi App Tec, Inc.

11.26.1 Wuxi App Tec, Inc. Company Details

11.26.2 Wuxi App Tec, Inc. Business Overview

11.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Introduction

11.26.4 Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.26.5 Wuxi App Tec, Inc. Recent Developments

11.27 ReNeuron Group plc

11.27.1 ReNeuron Group plc Company Details

11.27.2 ReNeuron Group plc Business Overview

11.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction

11.27.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.27.5 ReNeuron Group plc Recent Developments

11.28 Richter-Helm BioLogics GmbH & Co. KG

11.28.1 Richter-Helm BioLogics GmbH & Co. KG Company Details

11.28.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview

11.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction

11.28.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.28.5 Richter-Helm BioLogics GmbH & Co. KG Recent Developments

11.29 RoosterBio, Inc

11.29.1 RoosterBio, Inc Company Details

11.29.2 RoosterBio, Inc Business Overview

11.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction

11.29.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.29.5 RoosterBio, Inc Recent Developments

11.30 RoslinCT

11.30.1 RoslinCT Company Details

11.30.2 RoslinCT Business Overview

11.30.3 RoslinCT Cell Therapy and Tissue Engineering Introduction

11.30.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)

11.30.5 RoslinCT Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Betalin Therapeutics

BioCardia

BioReliance Corporation

Biosolution Co.

Brainstorm Cell Therapeutics Inc.

MaxCyte

MediGene AG

MediPost Co Ltd

Mesoblast Limited

Miromatrix Medical, Inc.

Molmed

Mustang Bio, Inc

NantKwest Inc

Neuralstem Inc

NexImmune, Inc.

Nohla Therapeutics Inc

Rubius Therapeutics, Inc.

Sangamo Therapeutics, Inc.

Voyager Therapeutics Inc

Waisman Biomanufacturing

WindMIL Therapeutics, Inc.

Wuxi App Tec, Inc.

ReNeuron Group Plc

Richter-Helm BioLogics GmbH & Co. KG

RoosterBio, Inc

RoslinCT

List of Tables

Table 1. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Cell Therapy

Table 3. Key Players of Tissue Engineering

Table 4. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Cell Therapy and Tissue Engineering Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cell Therapy and Tissue Engineering Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Cell Therapy and Tissue Engineering Market Share by Region (2019-2024)

Table 8. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Cell Therapy and Tissue Engineering Market Share by Region (2025-2030)

Table 10. Cell Therapy and Tissue Engineering Market Trends

Table 11. Cell Therapy and Tissue Engineering Market Drivers

Table 12. Cell Therapy and Tissue Engineering Market Challenges

Table 13. Cell Therapy and Tissue Engineering Market Restraints

Table 14. Global Cell Therapy and Tissue Engineering Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Cell Therapy and Tissue Engineering Revenue Share by Players (2019-2024)

Table 16. Global Top Cell Therapy and Tissue Engineering by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Tissue Engineering as of 2023)

Table 17. Global Cell Therapy and Tissue Engineering Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Cell Therapy and Tissue Engineering Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Cell Therapy and Tissue Engineering, Headquarters and Area Served

Table 20. Global Key Players of Cell Therapy and Tissue Engineering, Product and Application

Table 21. Global Key Players of Cell Therapy and Tissue Engineering, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2019-2024)

Table 25. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2025-2030)

Table 27. Global Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Cell Therapy and Tissue Engineering Revenue Share by Application (2019-2024)

Table 29. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Cell Therapy and Tissue Engineering Revenue Share by Application (2025-2030)

Table 31. North America Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Cell Therapy and Tissue Engineering Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Cell Therapy and Tissue Engineering Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Cell Therapy and Tissue Engineering Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Cell Therapy and Tissue Engineering Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Cell Therapy and Tissue Engineering Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Cell Therapy and Tissue Engineering Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Cell Therapy and Tissue Engineering Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Cell Therapy and Tissue Engineering Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Cell Therapy and Tissue Engineering Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country (2025-2030) & (US$ Million)

Table 63. Betalin Therapeutics Company Details

Table 64. Betalin Therapeutics Business Overview

Table 65. Betalin Therapeutics Cell Therapy and Tissue Engineering Product

Table 66. Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 67. Betalin Therapeutics Recent Developments

Table 68. BioCardia, Inc Company Details

Table 69. BioCardia, Inc Business Overview

Table 70. BioCardia, Inc Cell Therapy and Tissue Engineering Product

Table 71. BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 72. BioCardia, Inc Recent Developments

Table 73. BioReliance Corporation Company Details

Table 74. BioReliance Corporation Business Overview

Table 75. BioReliance Corporation Cell Therapy and Tissue Engineering Product

Table 76. BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 77. BioReliance Corporation Recent Developments

Table 78. Biosolution Co. Company Details

Table 79. Biosolution Co. Business Overview

Table 80. Biosolution Co. Cell Therapy and Tissue Engineering Product

Table 81. Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 82. Biosolution Co. Recent Developments

Table 83. Brainstorm Cell Therapeutics, Inc Company Details

Table 84. Brainstorm Cell Therapeutics, Inc Business Overview

Table 85. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product

Table 86. Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 87. Brainstorm Cell Therapeutics, Inc Recent Developments

Table 88. MaxCyte, Inc Company Details

Table 89. MaxCyte, Inc Business Overview

Table 90. MaxCyte, Inc Cell Therapy and Tissue Engineering Product

Table 91. MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 92. MaxCyte, Inc Recent Developments

Table 93. Medigene AG Company Details

Table 94. Medigene AG Business Overview

Table 95. Medigene AG Cell Therapy and Tissue Engineering Product

Table 96. Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 97. Medigene AG Recent Developments

Table 98. MEDIPOST CO. Company Details

Table 99. MEDIPOST CO. Business Overview

Table 100. MEDIPOST CO. Cell Therapy and Tissue Engineering Product

Table 101. MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 102. MEDIPOST CO. Recent Developments

Table 103. Mesoblast Limited Company Details

Table 104. Mesoblast Limited Business Overview

Table 105. Mesoblast Limited Cell Therapy and Tissue Engineering Product

Table 106. Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 107. Mesoblast Limited Recent Developments

Table 108. Miromatrix Medical, Inc. Company Details

Table 109. Miromatrix Medical, Inc. Business Overview

Table 110. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product

Table 111. Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 112. Miromatrix Medical, Inc. Recent Developments

Table 113. MolMed S.p.A Company Details

Table 114. MolMed S.p.A Business Overview

Table 115. MolMed S.p.A Cell Therapy and Tissue Engineering Product

Table 116. MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 117. MolMed S.p.A Recent Developments

Table 118. Mustang Bio, Inc Company Details

Table 119. Mustang Bio, Inc Business Overview

Table 120. Mustang Bio, Inc Cell Therapy and Tissue Engineering Product

Table 121. Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 122. Mustang Bio, Inc Recent Developments

Table 123. NantKwest, Inc. Company Details

Table 124. NantKwest, Inc. Business Overview

Table 125. NantKwest, Inc. Cell Therapy and Tissue Engineering Product

Table 126. NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 127. NantKwest, Inc. Recent Developments

Table 128. Neuralstem, Inc Company Details

Table 129. Neuralstem, Inc Business Overview

Table 130. Neuralstem, Inc Cell Therapy and Tissue Engineering Product

Table 131. Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 132. Neuralstem, Inc Recent Developments

Table 133. NexImmune, Inc. Company Details

Table 134. NexImmune, Inc. Business Overview

Table 135. NexImmune, Inc. Cell Therapy and Tissue Engineering Product

Table 136. NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 137. NexImmune, Inc. Recent Developments

Table 138. Nohla Therapeutics, Inc Company Details

Table 139. Nohla Therapeutics, Inc Business Overview

Table 140. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product

Table 141. Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 142. Nohla Therapeutics, Inc Recent Developments

Table 143. ReNeuron Group plc Company Details

Table 144. ReNeuron Group plc Business Overview

Table 145. ReNeuron Group plc Cell Therapy and Tissue Engineering Product

Table 146. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 147. ReNeuron Group plc Recent Developments

Table 148. Richter-Helm BioLogics GmbH & Co. KG Company Details

Table 149. Richter-Helm BioLogics GmbH & Co. KG Business Overview

Table 150. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product

Table 151. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 152. Richter-Helm BioLogics GmbH & Co. KG Recent Developments

Table 153. RoosterBio, Inc Company Details

Table 154. RoosterBio, Inc Business Overview

Table 155. RoosterBio, Inc Cell Therapy and Tissue Engineering Product

Table 156. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 157. RoosterBio, Inc Recent Developments

Table 158. RoslinCT Company Details

Table 159. RoslinCT Business Overview

Table 160. RoslinCT Cell Therapy and Tissue Engineering Product

Table 161. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 162. RoslinCT Recent Developments

Table 163. Rubius Therapeutics, Inc. Company Details

Table 164. Rubius Therapeutics, Inc. Business Overview

Table 165. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product

Table 166. Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 167. Rubius Therapeutics, Inc. Recent Developments

Table 168. Sangamo Therapeutics, Inc Company Details

Table 169. Sangamo Therapeutics, Inc Business Overview

Table 170. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product

Table 171. Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 172. Sangamo Therapeutics, Inc Recent Developments

Table 173. Voyager Therapeutics, Inc Company Details

Table 174. Voyager Therapeutics, Inc Business Overview

Table 175. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product

Table 176. Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 177. Voyager Therapeutics, Inc Recent Developments

Table 178. Waisman Biomanufacturing Company Details

Table 179. Waisman Biomanufacturing Business Overview

Table 180. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product

Table 181. Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 182. Waisman Biomanufacturing Recent Developments

Table 183. WindMIL Therapeutics, Inc. Company Details

Table 184. WindMIL Therapeutics, Inc. Business Overview

Table 185. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product

Table 186. WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 187. WindMIL Therapeutics, Inc. Recent Developments

Table 188. Wuxi App Tec, Inc. Company Details

Table 189. Wuxi App Tec, Inc. Business Overview

Table 190. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product

Table 191. Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 192. Wuxi App Tec, Inc. Recent Developments

Table 193. ReNeuron Group plc Company Details

Table 194. ReNeuron Group plc Business Overview

Table 195. ReNeuron Group plc Cell Therapy and Tissue Engineering Product

Table 196. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 197. ReNeuron Group plc Recent Developments

Table 198. Richter-Helm BioLogics GmbH & Co. KG Company Details

Table 199. Richter-Helm BioLogics GmbH & Co. KG Business Overview

Table 200. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product

Table 201. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 202. Richter-Helm BioLogics GmbH & Co. KG Recent Developments

Table 203. RoosterBio, Inc Company Details

Table 204. RoosterBio, Inc Business Overview

Table 205. RoosterBio, Inc Cell Therapy and Tissue Engineering Product

Table 206. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 207. RoosterBio, Inc Recent Developments

Table 208. RoslinCT Company Details

Table 209. RoslinCT Business Overview

Table 210. RoslinCT Cell Therapy and Tissue Engineering Product

Table 211. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)

Table 212. RoslinCT Recent Developments

Table 213. Research Programs/Design for This Report

Table 214. Key Data Information from Secondary Sources

Table 215. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Cell Therapy and Tissue Engineering Market Share by Type: 2023 VS 2030

Figure 3. Cell Therapy Features

Figure 4. Tissue Engineering Features

Figure 5. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Cell Therapy and Tissue Engineering Market Share by Application: 2023 VS 2030

Figure 7. Cell Defects Case Studies

Figure 8. Genetic Diseases Case Studies

Figure 9. Neurodegenerative Diseases Case Studies

Figure 10. Tissue Malignancies Case Studies

Figure 11. Others Case Studies

Figure 12. Cell Therapy and Tissue Engineering Report Years Considered

Figure 13. Global Cell Therapy and Tissue Engineering Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Cell Therapy and Tissue Engineering Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Cell Therapy and Tissue Engineering Market Share by Region: 2023 VS 2030

Figure 16. Global Cell Therapy and Tissue Engineering Market Share by Players in 2023

Figure 17. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Tissue Engineering as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Cell Therapy and Tissue Engineering Revenue in 2023

Figure 19. North America Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)

Figure 21. North America Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)

Figure 22. North America Cell Therapy and Tissue Engineering Market Share by Country (2019-2030)

Figure 23. United States Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Cell Therapy and Tissue Engineering Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)

Figure 27. Europe Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)

Figure 28. Europe Cell Therapy and Tissue Engineering Market Share by Country (2019-2030)

Figure 29. Germany Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Cell Therapy and Tissue Engineering Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)

Figure 37. China Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)

Figure 38. Asia Cell Therapy and Tissue Engineering Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)

Figure 40. Asia Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)

Figure 41. Asia Cell Therapy and Tissue Engineering Market Share by Region (2019-2030)

Figure 42. Japan Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Country (2019-2030)

Figure 52. Brazil Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Betalin Therapeutics Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 59. BioCardia, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 60. BioReliance Corporation Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 61. Biosolution Co. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 62. Brainstorm Cell Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 63. MaxCyte, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 64. Medigene AG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 65. MEDIPOST CO. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 66. Mesoblast Limited Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 67. Miromatrix Medical, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 68. MolMed S.p.A Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 69. Mustang Bio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 70. NantKwest, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 71. Neuralstem, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 72. NexImmune, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 73. Nohla Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 74. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 75. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 76. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 77. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 78. Rubius Therapeutics, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 79. Sangamo Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 80. Voyager Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 81. Waisman Biomanufacturing Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 82. WindMIL Therapeutics, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 83. Wuxi App Tec, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 84. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 85. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 86. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 87. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cell Therapy Regenerative Medicine Market Research Report 2025

Global Cell Therapy Market Insights Forecast to 2030

Engineered Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stem Cell Biomanufacturing Market Research Report 2024

Global Cell Therapy Biomanufacturing Market Research Report 2024

Global Stem Cell Treatments Market Insights Forecast to 2030

Global Cell Engineering Service Market Research Report 2024

Global Cellular Therapy CT Market Insights Forecast to 2030

Global Stem Cell Therapy Market Insights Forecast to 2030

Global Cellular Therapy Products Market Research Report 2024

Global Cell therapy platform Market Research Report 2024

Global Cell Therapy Instrument Market Insights Forecast to 2030

Tissue Engineered Products TEP Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tissue Engineering and Regeneration Market Research Report 2025

Global Cell and Gene Therapy Services Market Research Report 2024

Global Autologous Cell Therapy Market Insights Forecast to 2030

Global Cell Transplantatio Therapy Market Insights Forecast to 2030

Global Cell Processing Systems for Cell Therapy Market Research Report 2024

Global Musculoskeletal Disorder Stem Cell Therapy Market Insights Forecast to 2030

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16G6108

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-27Q5892

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14K19926

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15N17310

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions